Dual influenza & COVID-19 vaccine administration: Novavax announces positive results

Co-administration of Novavax’s COVID-19 vaccine candidate and an approved influenza vaccine induced robust immune responses, according to data from a clinical trial. “The findings suggest simultaneous vaccination may be a viable immunization strategy,” says the company.